278 related articles for article (PubMed ID: 21613335)
21. Water content and myelin water fraction in multiple sclerosis. A T2 relaxation study.
Laule C; Vavasour IM; Moore GR; Oger J; Li DK; Paty DW; MacKay AL
J Neurol; 2004 Mar; 251(3):284-93. PubMed ID: 15015007
[TBL] [Abstract][Full Text] [Related]
22. Multiple sclerosis and Alzheimer's disease.
Dal Bianco A; Bradl M; Frischer J; Kutzelnigg A; Jellinger K; Lassmann H
Ann Neurol; 2008 Feb; 63(2):174-83. PubMed ID: 17924575
[TBL] [Abstract][Full Text] [Related]
23. Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS.
Lindberg RL; De Groot CJ; Certa U; Ravid R; Hoffmann F; Kappos L; Leppert D
J Neuroimmunol; 2004 Jul; 152(1-2):154-67. PubMed ID: 15223248
[TBL] [Abstract][Full Text] [Related]
24. Progranulin in frontotemporal lobar degeneration and neuroinflammation.
Ahmed Z; Mackenzie IR; Hutton ML; Dickson DW
J Neuroinflammation; 2007 Feb; 4():7. PubMed ID: 17291356
[TBL] [Abstract][Full Text] [Related]
25. Enhanced number and activity of mitochondria in multiple sclerosis lesions.
Witte ME; Bø L; Rodenburg RJ; Belien JA; Musters R; Hazes T; Wintjes LT; Smeitink JA; Geurts JJ; De Vries HE; van der Valk P; van Horssen J
J Pathol; 2009 Oct; 219(2):193-204. PubMed ID: 19591199
[TBL] [Abstract][Full Text] [Related]
26. Preactive lesions in multiple sclerosis.
van der Valk P; Amor S
Curr Opin Neurol; 2009 Jun; 22(3):207-13. PubMed ID: 19417567
[TBL] [Abstract][Full Text] [Related]
27. Neuroinflammation and demyelination in multiple sclerosis after allogeneic hematopoietic stem cell transplantation.
Lu JQ; Joseph JT; Nash RA; Storek J; Stevens AM; Metz LM; Clark AW; Johnson ES; Yong VW
Arch Neurol; 2010 Jun; 67(6):716-22. PubMed ID: 20558390
[TBL] [Abstract][Full Text] [Related]
28. Microglia-derived macrophages in early multiple sclerosis plaques.
Li H; Cuzner ML; Newcombe J
Neuropathol Appl Neurobiol; 1996 Jun; 22(3):207-15. PubMed ID: 8804022
[TBL] [Abstract][Full Text] [Related]
29. Progranulin (PGRN) expression in ALS: an immunohistochemical study.
Irwin D; Lippa CF; Rosso A
J Neurol Sci; 2009 Jan; 276(1-2):9-13. PubMed ID: 18848708
[TBL] [Abstract][Full Text] [Related]
30. Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels.
Cunnea P; McMahon J; O'Connell E; Mashayekhi K; Fitzgerald U; McQuaid S
Acta Neuropathol; 2010 May; 119(5):601-15. PubMed ID: 19967542
[TBL] [Abstract][Full Text] [Related]
31. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.
Oh J; Pelletier D; Nelson SJ
Arch Neurol; 2004 Jul; 61(7):1081-6. PubMed ID: 15262739
[TBL] [Abstract][Full Text] [Related]
32. TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions.
Satoh J; Tabunoki H; Yamamura T; Arima K; Konno H
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):99-107. PubMed ID: 17239012
[TBL] [Abstract][Full Text] [Related]
33. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
Leitner H
Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
[TBL] [Abstract][Full Text] [Related]
34. Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
Cristofanilli M; Rosenthal H; Cymring B; Gratch D; Pagano B; Xie B; Sadiq SA
Exp Neurol; 2014 Nov; 261():620-32. PubMed ID: 25111532
[TBL] [Abstract][Full Text] [Related]
35. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis.
Kooi EJ; Geurts JJ; van Horssen J; Bø L; van der Valk P
J Neuropathol Exp Neurol; 2009 Sep; 68(9):1021-8. PubMed ID: 19680141
[TBL] [Abstract][Full Text] [Related]
36. Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid.
Sarchielli P; Greco L; Floridi A; Floridi A; Gallai V
Arch Neurol; 2003 Aug; 60(8):1082-8. PubMed ID: 12925363
[TBL] [Abstract][Full Text] [Related]
37. Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis.
Saikali P; Antel JP; Pittet CL; Newcombe J; Arbour N
J Immunol; 2010 Nov; 185(10):5693-703. PubMed ID: 20926794
[TBL] [Abstract][Full Text] [Related]
38. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease.
Vrenken H; Pouwels PJ; Ropele S; Knol DL; Geurts JJ; Polman CH; Barkhof F; Castelijns JA
Mult Scler; 2007 Jul; 13(6):708-16. PubMed ID: 17613597
[TBL] [Abstract][Full Text] [Related]
39. Gender differences in the histopathology of MS?
Kuhlmann T; Goldschmidt T; Antel J; Wegner C; König F; Metz I; Brück W
J Neurol Sci; 2009 Nov; 286(1-2):86-91. PubMed ID: 19674757
[TBL] [Abstract][Full Text] [Related]
40. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.
Parry A; Clare S; Jenkinson M; Smith S; Palace J; Matthews PM
J Neurol; 2002 Sep; 249(9):1279-86. PubMed ID: 12242554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
